Redhill Biopharma Ltd-sp Adr share price logo

Redhill Biopharma Ltd-sp Adr Share Price

NASDAQ: RDHL

Small Cap

$1.50

-0.01

(-0.66%)

as on

Redhill Biopharma Ltd-sp Adr Stock Performance

as on September 16, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $1.47
    $1.52
    downward going graph

    2.00%

    Downside

    1.33%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.06
    $11.7
    downward going graph

    29.33%

    Downside

    680.00%

    Upside

    downward going graph

Redhill Biopharma Ltd-sp Adr share price movements today

Previous Close
$1.51
Open
$1.48
Volume
172.5K
Day's Low - High
$1.47 - $1.52
52 Week Low - High
$1.06 - $11.7

Redhill Biopharma Ltd-sp Adr Historical Returns

1 Month Return
+ 11.03 %
3 Month Return
-13.71 %
1 Year Return
-86.29 %
3 Year Return
-99.81 %
5 Year Return
-99.99 %

Redhill Biopharma Ltd-sp Adr Stock Fundamentals & Key Indicators

Check Redhill Biopharma Ltd-sp Adr market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.5M

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-8.3M

Revenue (TTM)

9.6M

Profit Margin

-97.52%

Return On Equity TTM

-1708.61%

Redhill Biopharma Ltd-sp Adr vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Redhill Biopharma Ltd-sp Adr with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$3.5M-99.99%NA-97.52%
BUY$18.3BNA15.840.36%
BUY$44.1BNA21.813.81%
BUY$14.1B36.02%41.9713.88%
BUY$65.7B-8.68%25.5127.83%

Stock Returns calculator for Redhill Biopharma Ltd-sp Adr Stock including INR - Dollar returns

The Redhill Biopharma Ltd-sp Adr stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Redhill Biopharma Ltd-sp Adr investment value today

Current value as on today

₹18,609

Returns

₹81,391

(-81.39%)

Returns from Redhill Biopharma Ltd-sp Adr Stock

₹86,376 (-86.38%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Redhill Biopharma Ltd-sp Adr Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Redhill Biopharma Ltd-sp Adr. Average target price of $19000

Redhill Biopharma Ltd-sp Adr Share Price Target

Get share price movements and forecasts by analysts on Redhill Biopharma Ltd-sp Adr.

What analysts predicted

99.99%UPSIDE

Target Price

$19000

Current Price

$1.5

Analyzed by

7 Analysts

Target

$19000.00

Redhill Biopharma Ltd-sp Adr target price $19000, a slight upside of 99.99% compared to current price of $1.5. According to 7 analysts rating.

Redhill Biopharma Ltd-sp Adr Stock's Interest Amongst Investors

Search interest for Redhill Biopharma Ltd-sp Adr Stock has decreased by -30% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-30% versus previous 30 day period

Redhill Biopharma Ltd-sp Adr Quarterly Profit & Loss

All numbers in Millions USD

Jun 2022
Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Total Revenue
18
17
12
12
1
0
1
1
2
2
Gross Profit
9
8
4
4
0
0
0
0
1
1
Operating Income
-9
-7
-9
-9
-4
-6
-4
-4
-3
-3
EBITDA
-5
-1
0
0
2
-5
-4
-4
-1
-1
Interest Expense
4
31
1
0
1
-
-
-
-
-
Depreciation
1
2
2
60
-58
-
-
-
-
-
Income Before Tax
-11
-35
-3
-3
0
-13
-1
-1
-2
-2
Income Tax Expense
2
28
-6
-6
0
-
-
-
-
-
Net Income
-14
-35
2
-3
0
-13
-1
-1
-2
-2
Net Profit Margin
-77.74%
-203.40%
19.46%
-29.14%
42.37%
-2386.43%
-120.06%
-120.06%
-94.68%
-94.68%

Redhill Biopharma Ltd-sp Adr Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
0
0
4
8
6
64
85
61
6
8
Gross Profit
-21
-30
1
5
4
27
36
28
3
4
Operating Income
-22
-30
-51
-39
-43
-63
-81
-42
12
-14
EBITDA
-21
-30
-45
-38
-40
-54
-63
-42
26
-7
Interest Expense
0
0
0
0
0
12
16
0
0
0
Depreciation
-
-
0
0
1
8
18
8
1
0
Income Before Tax
-21
-29
-45
-38
-42
-76
-97
-71
23
-8
Income Tax Expense
0
1
6
0
1
12
16
-12
0
-
Net Income
-21
-29
-45
-38
-42
-76
-97
-71
23
-8
Net Profit Margin
-703000.00%
-29079.21%
-1136.61%
-464.35%
-672.45%
-118.36%
-113.98%
-115.97%
367.19%
-102.80%

Redhill Biopharma Ltd-sp Adr Quarterly Cash Flow

All numbers in Millions USD

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Net Income
-3
-3
0
-13
-13
-1
-1
-2
-2
Operating Cash Flow
-2
-2
-10
-9
-
-3
-3
-1
-1
Investing Cash Flow
-
-8
0
0
-
0
0
0
0
Financing Cash Flow
7
7
0
8
-
3
3
0
0
Change in Cash
4
4
-10
-6
-
-
-
-
-

Redhill Biopharma Ltd-sp Adr Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-29
-45
-38
-42
-76
-97
-71
23
-8
Operating Cash Flow
-28
-44
-34
-40
-48
-65
-29
-35
-9
Investing Cash Flow
24
-18
5
5
-35
-8
8
0
0
Financing Cash Flow
36
25
41
35
84
73
11
21
8
Change in Cash
32
-37
12
0
0
0
-9
-14
0

Global Institutional Holdings in Redhill Biopharma Ltd-sp Adr

Funds
Holdings
Citadel Advisors Llc
0.94%
Federation des caisses Desjardins du Quebec
0.15%
GAMMA Investing LLC
0.09%
Rhumbline Advisers
0.06%
Bank of America Corp
0.01%

Insights on Redhill Biopharma Ltd-sp Adr

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 5 quarters, 567.5K → 2.73M (in $), with an average increase of 27.2% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, United Therapeutics Corporation has given 19.4% return, outperforming this stock by 105.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation has given 83.6% return, outperforming this stock by 183.4%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, -1.54M → -2.59M (in $), with an average decrease of 33.9% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, RDHL stock has moved down by -41.0%

About Redhill Biopharma Ltd-sp Adr

redhill biopharma is a biopharmaceutical company focused primarily on development of late clinical-stage new, improved and patented formulations of existing drugs. redhill has an experienced management team, board of directors and advisory board based in israel, the us, canada and europe, with successful track record at big and small pharma of bringing patented drugs to the market, as well as extensive managerial, financial, and transactional expertise
OrganisationRedhill Biopharma Ltd-sp Adr
Headquarters21 Ha?arba?a Street, Tel Aviv, Israel, 6473921
IndustryHealth Technology
CEOMr. Dror Ben-Asher
E-voting on sharesClick here to vote

Key Management of Redhill Biopharma Ltd-sp Adr

Name

Title

Mr. Dror Ben-Asher

Co-Founder, Chairman & CEO

Mr. Adi Frish

Chief Corporate & Business Development Officer

Dr. Reza Fathi Ph.D.

Senior Vice President of Research & Development

Mr. Guy Goldberg J.D.

Chief Business Officer

Mr. Razi Ingber

Chief Financial Officer

Mr. Rick D. Scruggs

Chief Commercial Officer & Director

Mr. Gilead Raday MPhil, MSc

Chief Operating Officer

Dr. Mark L. Levitt M.D., Ph.D.

Chief Scientific Officer

Ms. Alexandra Okmian

Senior Business Development & Investor Relations Manager

Ms. Patricia Anderson B.Sc. RAC

Senior Vice President of Regulatory Affairs

FAQs

What is Redhill Biopharma Ltd-sp Adr share price today?

Redhill Biopharma Ltd-sp Adr share price today is $1.5 as on at the close of the market. Redhill Biopharma Ltd-sp Adr share today touched a day high of $1.52 and a low of $1.47.

What is the 52 week high and 52 week low for Redhill Biopharma Ltd-sp Adr share?

Redhill Biopharma Ltd-sp Adr share touched a 52 week high of $11.7 on and a 52 week low of $1.06 on . Redhill Biopharma Ltd-sp Adr stock price today i.e. is closed at $1.5,which is 87.18% down from its 52 week high and 41.51% up from its 52 week low.

What is Redhill Biopharma Ltd-sp Adr's market capitalisation today?

Redhill Biopharma Ltd-sp Adr market capitalisation is $0.00T as on .

How to invest in Redhill Biopharma Ltd-sp Adr Stock (RDHL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Redhill Biopharma Ltd-sp Adr on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Redhill Biopharma Ltd-sp Adr Shares that will get you 1.0000 shares as per Redhill Biopharma Ltd-sp Adr share price of $1.5 per share as on September 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Redhill Biopharma Ltd-sp Adr Stock (RDHL) from India?

Indian investors can start investing in Redhill Biopharma Ltd-sp Adr (RDHL) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Redhill Biopharma Ltd-sp Adr stock (as per the Rupee-Dollar exchange rate as on ). Based on Redhill Biopharma Ltd-sp Adr share’s latest price of $1.5 as on September 16, 2025 at 1:29 am IST, you will get 6.6667 shares of Redhill Biopharma Ltd-sp Adr. Learn more about fractional shares .

What are the returns that Redhill Biopharma Ltd-sp Adr has given to Indian investors in the last 5 years?

Redhill Biopharma Ltd-sp Adr stock has given -99.99% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?